manidipine has been researched along with Aging in 1 studies
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of the present study was to compare the pharmacokinetic and pharmacodynamic properties of a fixed combination tablet containing 10 mg of manidipine dihydrochloride (CAS 89226-75-5), a calcium channel antagonist, and 30 mg of delapril hydrochloride (CAS 83435-67-0), an angiotensin converting enzyme (ACE) inhibitor, during once daily repeated dosing in young and elderly subjects and to assess the bioequivalence of the fixed combination tablet and the single ingredient tablets taken simultaneously in young healthy subjects after a single dose administration." | 2.71 | Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects. ( Acerbi, D; De Bruyn, S; Gengler, C; Goethals, F; Lens, S; Poli, G; Stockis, A, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stockis, A | 1 |
De Bruyn, S | 1 |
Gengler, C | 1 |
Goethals, F | 1 |
Lens, S | 1 |
Poli, G | 1 |
Acerbi, D | 1 |
1 trial available for manidipine and Aging
Article | Year |
---|---|
Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects.
Topics: Adolescent; Adult; Aged; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; A | 2003 |